Treatment of Overweight Induced by Antipsychotic Medication in Young People with Autism Spectrum Disorders

Treatment of Overweight Induced by Antipsychotic Medication in Young People with Autism Spectrum Disorders

Status

This study is closed and is no longer recruiting participants.



Principal Investigator

Dr. Evdokia Anagnostou



Purpose

This is a study investigating whether Riomet® (metformin) can decrease weight gain caused by certain medications: Abilify (Aripiprazole), Risperdal (Risperidone), Seroquel (Quetiapine), Zyprexa (Olanzapine), Saphris (Asenapine Maleate), Clozaril (Clozapine), Fanapt (Iloperidone), Latuda (Lurasidone), Zeldox (Ziprasidone), Invega (Paliperidone). These medications are commonly used to improve irritability, agitation, and repetitive behaviours in young people with ASD.



Who

6-17 year olds with ASD



What

32 Week (8 Month) clinical trial intervention study taking medication every day. Visits will take place every month plus extra visits for outcome measure assessments and labs.



Where

Holland Bloorview



Recruitment

Closed